查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830117

HIFU（高强度聚焦超音波）设备市场（按指导、交付模式、技术、产品、应用和最终用户）—2025-2032 年全球预测

High Intensity Focused Ultrasound Devices Market by Guidance, Delivery Mode, Technology, Product, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，HIFU（高强度聚焦超音波）设备市场规模将成长至 63.5 亿美元，复合年增长率为 10.82%。

主要市场统计数据
基准年2024年 27.9亿美元
预计2025年 30.9亿美元
预测年份：2032年 63.5亿美元
复合年增长率（%） 10.82%

高强度聚焦超音波(HIFU) 设备正在从实验平台转型为跨多个专业领域、影响深远的临床工具。本介绍将透过探讨临床需求、技术成熟度和监管演变之间的相互作用，为当前的生态系统提供一个框架。近年来，非侵入性和微创工作流程已得到验证，这加速了临床医生的兴趣，而更多样化的设备外形规格也拓宽了其应用途径。这些趋势与日益复杂的报销模式交织在一起，早期积极的临床结果推动着付款人的参与和机构的投资决策。

临床发展势头受到多种因素的推动，包括影像引导的改进、通讯协定的清晰化以及训练有素的操作人员数量的不断增加。同时，製造商正在改进设备的人体工学设计、能量传输以及与医院资讯系统的集成，以提高吞吐量和易用性。主要市场的监管机构也在调整应用途径以适应新型治疗方法，这些疗法与可靠证据的产生相结合，正在缩短临床应用的时间。这些因素共同创造了一个充满活力的环境，其中策略清晰度、营运准备度和证据一致性将决定哪些相关人员将持续受益于该技术的前景。

转型重塑病患治疗路径、报销框架、跨领域合作以及聚焦超音波治疗的技术格局

聚焦超音波治疗领域正在经历变革时期，这场变革正在改变临床路径、竞争格局以及支付者和提供者的期望。引导系统和治疗计划软体的进步使得治疗过程更加可预测且可重复，而这项技术进步正在推动培训模式和医院工作流程的后续变革。随着设备应用的不断增加，评估不仅要考虑疗效，还要考虑吞吐量、总手术成本以及与现有影像处理设备的互通性。

同时，报销框架正从特定适应症的实验应用转向更结构化的路径，从而改变财务奖励并鼓励更大规模的推广应用。放射科、肿瘤科和外科之间的跨学科合作正在催生混合医疗模式，将聚焦超音波作为手术或全身性治疗的辅助或替代手段。商业策略正在透过多样化的市场化方式应对，这些方式结合了直接的医院合作、专科诊所参与以及扩展的服务范围。成功的公司将是那些能够将研发重点与实际临床需求相结合，并在各种医疗环境中展示营运和经济价值的公司。

评估 2025 年美国征收关税对供应链、采购经济、协作和医疗设备可近性的累积影响

2025年美国关税的实施，对超音波设备生态系统产生了累积效应，影响了采购经济性、供应链设计和国际合作模式。关税导致进口零件和组件成本上升，促使设备製造商重新评估其筹资策略，强调供应商多元化，并尽可能进行近岸外包。虽然这些供应链调整降低了单一来源中断的风险，但也带来了过渡成本，并增加了供应商资格认证和品管的复杂性。

医院和专科诊所的采购团队已采取措施，加强供应商评估，并明确总拥有成本的计算。对于那些依赖长期跨国製造伙伴关係的公司来说，关税加速了他们做出在地化组装和与经销商重新谈判条款的决策。这也对监管和临床实验状况产生了间接影响。营运成本的上升正在推迟患者入组奖励，并增加了进行多中心试验的成本，最终影响证据产生的时间表。

最后，关税促使经营团队经营团队制定更严谨的情境规划，在短期利润保护措施与供应链韧性和成本工程的长期投资之间取得平衡。最终结果是，策略重点重新调整，转向营运敏捷性、供应商风险管理，以及与面临资本预算紧张的采购相关人员进行清晰的价值沟通。

细分洞察揭示了影像引导、交付模式、技术选择、产品类型、临床使用和最终用户偏好如何影响采用

了解细分市场的细微差别，可以揭示临床、技术和商业性选择如何在不同环境下驱动不同的采用模式。本分析考虑了核磁共振引导和超音波引导的影像引导，这两种引导方式形成了截然不同的临床工作流程。核磁共振引导的手术能够提供更出色的软组织可视化和温度测量，但成本更高，并且需要专门的设施。另一方面，超音波引导系统允许更广泛的照护现场应用和程序灵活性。给药方式根据体外、间质和腔内途径区分，每种途径都适用于不同的临床团队、基础设施需求和患者选择标准。技术选择也是一个变化的轴心，与热感消融相比，机械消融具有独特的机械生物学优势。

产品形式多样，从可携式到固定式，部署意义重大。可携式系统方便门诊和门诊病人环境使用，而固定平台则针对高容量医院设施进行了最佳化，并配备了先进的影像整合技术。肝肿瘤、胰臟肿瘤、摄护腺癌和子宫肌瘤等临床应用各自有其独特的证据需求、转诊途径和报销考量，因此临床采用的速度也各不相同。终端使用者细分包括门诊手术中心、医院和专科诊所，这些环境的资本购买週期、人员配备模式和预期手术量各不相同。了解这些细分轴如何交叉，可以实现更有针对性的产品开发、证据生成和商业化策略，使技术属性与临床和营运实际情况一致。

比较全球各区域的驱动因素、基础设施准备、监管方法、报销动态和临床采用模式的区域见解

区域动态在聚焦超音波技术的采用、推广和报销方式方面发挥着至关重要的作用。在美洲，领先的卓越中心和相对快速发展的商业支付市场支持了该技术在某些适应症中的早期临床应用。从早期应用到更广泛的机构应用的过渡需要临床负责人和采购决策者之间的合作，而区域报销环境通常决定了这一过渡的时机。

在欧洲、中东和非洲，监管和报销格局差异较大，国家层级的决策和多样化的医疗服务提供模式需要製定区域合作策略。在某些司法管辖区，集中式卫生技术评估流程提高了证据门槛，而在其他司法管辖区，利基报销途径则有助于实现有针对性的部署。因此，製造商必须根据各国支付方预期和医院资金筹措的差异，量身订做其临床和经济性材料。

亚太地区正因基础设施投资和日益增长的微创手术需求而创造着巨大的商机，但打入市场策略必须考虑到多样化的管理体制、多样化的影像实施以及多样化的医院采购惯例。任何地区的成功扩张都取决于能否展现清晰的临床价值、营运相容性以及符合当地医疗保健重点和资源限制的永续服务模式。

产品平臺、战略伙伴关係关係、生产规模、监管进展和市场进入定位的竞争企业资料

聚焦超音波领域的公司层面动态呈现竞争、合作和策略专业化交织的特征。领先的研发商正在推行双重策略：一方面提升核心技术能力，另一方面建立伙伴关係关係，以扩大临床覆盖范围和服务能力。投资通常专注于改进治疗计划软体、增强影像整合以及降低每次手术的复杂性，从而降低培训门槛并扩展可用配置。生产规模和品质系统正成为竞争定位的核心，尤其是在设备从早期临床应用转向常规医院运作的情况下。

与学术中心和临床网络建立策略联盟仍然是加速证据产生和建立卓越中心的关键策略。同时，商业性差异化通常依赖捆绑培训、维护和成果支援的服务模式，以解决买家对营运风险的担忧。监管进展和审批被用来获得市场进入，但公司也强调上市后证据收集和真实世界数据倡议，以支持报销谈判。对于规模较小的创新者来说，与现有经销商和设备平台合作仍然是一条可行的市场途径，而规模较大的公司则寻求选择性收购，以填补技术或地理空白。竞争格局将有利于那些将临床检验与可扩展製造和现实商业化模式相结合的组织。

为产业领导者提供策略建议，以加速临床应用、优化供应链、调整报销方式并优先考虑研发

产业领导者应专注于一系列切实可行的优先事项，将策略意图与可衡量的成果连结起来。首先，将研发蓝图与临床工作流程结合，可确保设备功能降低程序复杂性并解决临床医师的痛点。投资以使用者为中心的设计和整合影像工作流程通常可以加快医疗机构的采用速度。其次，透过供应商多元化、本地组装和模组化组件策略来增强供应链的韧性，可以减轻关税的影响并减少前置作业时间的波动。

第三，证据策略应分层次实施。针对特定适应症、展现出显着疗效的临床项目必须辅以可操作的真实世界证据倡议，以支持报销讨论。门诊手术中心、医院和专科诊所都需要明确的定价、培训和服务套餐，并使其与购买行为相符。最后，与付款人、学术合作伙伴和系统整合商建立策略伙伴关係可以加速市场进入并拓宽转诊网路。透过设定清晰的指标、分配跨职能资源并保持敏捷的管治，能够将这些优先事项付诸实践的高阶主管将更有能力将技术前景转化为持续的临床和商业性影响。

严谨的调查方法，解释原始资料和二手资料、专家访谈、检验步骤、细分逻辑和分析技术

本分析所依据的调查方法遵循严格的一手和二手资料收集、专家检验和透明的细分逻辑。一手资料研究包括与临床意见领袖、采购专业人员和技术高管进行结构化访谈，以了解该观点对临床工作流程、实施障碍和采购重点的看法。二手资料研究利用同行评审文献、监管审批和公开文件，对临床结果、设备属性和路径演变进行三角测量。

检验步骤将访谈洞察与已发表资料最后覆核，而分析方法则将定性主题综合与结构化细分框架相结合，以得出可行的结论。细分逻辑将影像引导选项、交付模式、技术类别、产品外形规格、临床用途和最终用户偏好与观察到的采用行为和操作限制进行映射。在整个过程中，品管确保假设得到记录、来源可追溯，并且解释以经验证据为基础。

这种方法平衡了临床洞察的深度和操作的严谨性，相关人员提供了策略决策和后续分析的可靠基础。

结论：综合策略要点、新兴风险和机会，以及领导者在聚焦超音波领域应采取的行动

综上所述，高强度聚焦超音波的前景令人瞩目，既有临床前景，又有操作复杂性，需要采取严谨的策略行动。关键要点强调了将设备功能与临床工作流程相结合、展示清晰的以患者为中心的治疗结果，以及以对采购和报销相关人员有意义的方式体现价值的重要性。新兴风险包括供应链中断、不同司法管辖区的监管差异，以及需要强有力的证据来获得更广泛的付款方支持。

当技术属性能够减轻官僚负担、扩大医疗服务范围，并显着提升病患体验和医疗系统效率时，机会将汇聚。能够整合临床检验、可扩展生产和实用商业化的组织，将有可能获得最具永续性的优势。领导者应采取积极主动的立场，投资于供应链韧性，根据最终用户情况调整上市模式，并建立支付方和临床伙伴关係关係，以支持更广泛的应用。

最终，明确的策略重点、根据证据执行的能力和营运适应性将决定哪些相关人员能够成功地将创新转化为这个不断发展的治疗领域的持续临床和商业性影响。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 磁振造影引导的高强度聚焦超音波系统 (HIFU) 的出现，使得肿瘤学应用中的精确即时肿瘤消融成为可能
  • 患者疗效的改善和更快的康復推动了 HIFU 在非侵入性子宫肌瘤治疗中的应用
  • 扩大高强度聚焦超音波在自发性震颤和帕金森氏症等神经系统疾病的应用
  • 整合即时测温监测解决方案，提升HIFU组织消融手术的安全性和有效性
  • 开发紧凑型可携式HIFU 设备，以方便门诊和农村医疗环境中的照护现场治疗
  • 人们对先进的换能器阵列设计的兴趣日益浓厚，旨在改善 HIFU 平台的焦点控制和深度穿透
  • 监管部门的核准和不断演变的报销框架加速了HIFU在全球主要医疗保健市场的普及
  • 新兴通讯协定结合 HIFU 和放射疗法，协同作用，标靶治疗抗药性癌症病变
  • 提高超音波影像影像设备的整合度，在 HIFU 治疗期间提供引导式视觉化

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 HIFU（高强度聚焦超音波）设备市场指南

  • MRI 指南
  • 超音波引导

9. HIFU（高强度聚焦超音波）设备市场（依交付模式）

  • 体外
  • 插页式广告
  • 腔内

第 10 章 HIFU（高强度聚焦超音波）设备市场（按技术）

  • 机械消融
  • 热消融
    • 连续波
    • 脉搏波

第 11 章 HIFU（高强度聚焦超音波）设备市场（按产品）

  • 可携式的
  • 固定式

第 12 章 HIFU（高强度聚焦超音波）设备市场（按应用）

  • 肝臟肿瘤
  • 胰臟肿瘤
  • 摄护腺癌
  • 子宫肌瘤

第 13 章 HIFU（高强度聚焦超音波）设备市场（按最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

第14章。按地区分類的HIFU（高强度聚焦超音波）设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章 HIFU（高强度聚焦超音波）设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章。按国家分類的HIFU（高强度聚焦超音波）设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Chongqing Haifu Medical Technology Co., Ltd.
    • Insightec Ltd.
    • EDAP TMS SA
    • SonaCare Medical LLC
    • Alpinion Medical Systems Co., Ltd.
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Hitachi, Ltd.
    • THERACLION SA
Product Code: MRR-43539E5D36FD

The High Intensity Focused Ultrasound Devices Market is projected to grow by USD 6.35 billion at a CAGR of 10.82% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.79 billion
Estimated Year [2025] USD 3.09 billion
Forecast Year [2032] USD 6.35 billion
CAGR (%) 10.82%

High intensity focused ultrasound devices have moved from experimental platforms to influential clinical tools across multiple specialties, and this introduction frames the current ecosystem by examining the interplay of clinical need, technological maturity and regulatory evolution. Recent years have seen proof points in noninvasive and minimally invasive workflows that have accelerated clinician interest, while a more diverse set of device form factors has broadened pathways to adoption. These trends intersect with an increasingly complex reimbursement landscape, where early positive clinical outcomes are catalyzing payer engagement and institutional investment decisions.

Clinical momentum is supported by converging drivers: improved imaging guidance, clearer procedural protocols, and a growing cadre of trained operators. Concurrently, manufacturers are refining device ergonomics, energy delivery modalities and integration with hospital information systems to improve throughput and ease of use. Regulatory authorities in key markets have also adapted submission pathways to accommodate novel therapeutic modalities, which reduces time to clinical availability when paired with robust evidence generation. Taken together, these forces create a dynamic environment in which strategic clarity, operational readiness and evidence alignment will determine which stakeholders sustainably benefit from the technology's promise.

Transformations reshaping patient pathways, reimbursement frameworks, cross-disciplinary collaborations, and technological landscape in focused ultrasound therapies

The focused ultrasound landscape is undergoing transformative shifts that are altering clinical pathways, competitive dynamics and the expectations of payers and providers. Advances in guidance systems and treatment planning software are enabling more predictable, reproducible procedures, and this technical progress drives downstream changes in training models and hospital workflows. As adoption increases, devices are being evaluated not only on efficacy but also on throughput, total cost of procedure and interoperability with existing imaging suites.

In parallel, reimbursement frameworks are moving from experimental coverage toward more structured pathways in certain indications, shifting economic incentives and encouraging larger-scale deployments. Cross-disciplinary collaborations between radiology, oncology and surgical specialties are fostering hybrid care models that incorporate focused ultrasound as an adjunct or alternative to surgery or systemic therapy. Commercial strategies are responding with diversified go-to-market approaches that combine direct hospital partnerships, specialty clinic engagement and expanded service offerings. The outcome is a market that is more nuanced: success favors organizations that align R&D priorities with real-world clinical needs and that can demonstrate operational and economic value across a spectrum of care settings.

Assessment of the cumulative consequences of United States tariffs in 2025 on supply chains, procurement economics, collaboration and device accessibility

The introduction of United States tariffs in 2025 has produced cumulative effects across the focused ultrasound device ecosystem by influencing procurement economics, supply chain design and international collaboration patterns. Tariff-induced cost increases on imported components and subassemblies have prompted device manufacturers to re-evaluate sourcing strategies, emphasizing supplier diversification and nearshoring where feasible. These supply chain adaptations reduce exposure to single-source disruptions but also introduce transitional costs and complexity in vendor qualification and quality control.

Procurement teams at hospitals and specialty clinics have responded by tightening vendor evaluations and seeking clearer total-cost-of-ownership calculations, which now must account for tariff-inflated capital and consumable expenses. For companies that relied on long-standing cross-border manufacturing partnerships, tariffs have accelerated decisions to localize assembly or to renegotiate commercial terms with distributors. The regulatory and clinical trial landscape has also felt indirect effects: higher operational costs can slow enrollment incentives or increase the cost of running multi-center studies, which in turn affects evidence generation timelines.

Finally, the tariffs have incentivized more rigorous scenario planning among executives, who are balancing short-term margin protection tactics with longer-term investments in supply chain resilience and cost engineering. The net impact is a re-prioritization of strategic focus toward operational agility, supplier risk management and clearer communication of value to procurement stakeholders facing stretched capital budgets.

Segmentation insights revealing how imaging guidance, delivery mode, technology choice, product type, clinical application and end-user setting affect adoption

A nuanced understanding of segmentation reveals how clinical, technical and commercial choices drive differentiated adoption patterns across settings. This analysis considers imaging guidance across MRI Guided and Ultrasound Guided approaches, which create distinct clinical workflows: MRI-guided procedures offer superior soft-tissue visualization and thermometry yet demand higher capital intensity and specialized suites, while ultrasound-guided systems enable broader point-of-care use and procedural flexibility. Delivery mode is differentiated by Extracorporeal, Interstitial and Intracavitary approaches, and each mode aligns with different clinical teams, infrastructure requirements and patient selection criteria. Technology selection is another axis of variation, with Mechanical Ablation offering distinct mechanobiological effects compared with Thermal Ablation; within thermal approaches, the continuous wave and pulsed wave modalities present divergent safety profiles, energy management characteristics and procedural planning needs.

Product form factors range from Portable to Stationary devices, and that distinction has profound implications for deployment: portable systems facilitate ambulatory and outpatient settings, whereas stationary platforms are optimized for high-volume hospital suites with advanced imaging integration. Clinical applications-spanning Liver Tumor, Pancreatic Tumor, Prostate Cancer and Uterine Fibroids-each have unique evidence requirements, referral pathways and reimbursement considerations, and the pace of clinical adoption varies accordingly. End-user segmentation includes Ambulatory Surgical Centers, Hospitals and Specialty Clinics, and these settings differ in capital purchasing cycles, staffing models and procedural throughput expectations. Understanding how these segmentation axes intersect enables more targeted product development, evidence generation and commercialization strategies that match technology attributes to clinical and operational realities.

Regional insights comparing drivers, infrastructure readiness, regulatory approaches, reimbursement dynamics and clinical adoption patterns across world regions

Regional dynamics play a decisive role in shaping how focused ultrasound technologies are adopted, scaled and reimbursed. In the Americas, leading centers of excellence and a relatively fast-moving private payer market have supported early clinical uptake in selected indications, while robust academic networks have driven multicenter evidence generation. Transitioning from early adopters to broader institutional adoption requires alignment between clinical champions and procurement decision-makers, and the regional reimbursement environment often determines the timing of that transition.

Europe, Middle East & Africa presents a more heterogeneous regulatory and reimbursement landscape, where national-level decision-making and varied healthcare delivery models require localized engagement strategies. In some jurisdictions, centralized health technology assessment processes raise the bar for evidence, while in others niche reimbursement pathways enable targeted deployment. Manufacturers must therefore calibrate clinical and economic dossiers to account for national differences in payer expectations and hospital financing.

Across Asia-Pacific, infrastructure investments and rising demand for minimally invasive treatments are creating sizable opportunities, yet market entry strategies must account for diverse regulatory regimes, varying imaging adoption and differing hospital procurement practices. In all regions, successful expansion hinges on demonstrating clear clinical value, operational fit and sustainable service models that match local healthcare priorities and resource constraints.

Competitive company intelligence on product pipelines, strategic partnerships, manufacturing scale, regulatory progress and go-to-market positioning

Company-level dynamics in the focused ultrasound sector are characterized by a blend of competition, collaboration and strategic specialization. Leading developers are pursuing dual strategies: advancing core technology capabilities while forming partnerships that expand clinical reach and service capacity. Investment focus commonly includes improving treatment planning software, enhancing imaging integration and reducing per-procedure complexity to lower training thresholds and expand usable settings. Manufacturing scale and quality systems are increasingly central to competitive positioning, particularly as devices move from early clinical use into routine hospital operations.

Strategic alliances with academic centers and clinical networks remain a critical tactic for accelerating evidence generation and establishing centers of excellence. At the same time, commercial differentiation often hinges on service models that bundle training, maintenance and outcome support, addressing purchaser concerns about operational risk. Regulatory progress and clearances are leveraged to gain market access, but companies also emphasize post-market evidence collection and real-world data initiatives to support reimbursement conversations. For smaller innovators, partnering with established distributors or device platforms is a pragmatic route to market, while larger firms pursue selective acquisitions to fill technology or geographic gaps. The competitive landscape will favor organizations that integrate clinical validation with scalable manufacturing and pragmatic commercialization models.

Strategic recommendations enabling industry leaders to accelerate clinical adoption, optimize supply chains, align reimbursement approaches and prioritize R&D

Industry leaders should concentrate on a set of actionable priorities that translate strategic intent into measurable outcomes. First, aligning R&D roadmaps with clinical workflows will ensure that device features reduce procedural complexity and address clinician pain points; investments in user-centered design and integrated imaging workflows typically yield faster institutional adoption. Second, strengthening supply chain resilience through supplier diversification, localized assembly and modular component strategies can mitigate tariff exposure and reduce lead-time volatility.

Third, evidence strategies should be tiered: focused, indication-specific clinical programs that demonstrate meaningful patient outcomes must be complemented by pragmatic real-world evidence initiatives to support reimbursement discussions. Fourth, commercial models need to be tailored by end-user; ambulatory surgical centers, hospitals and specialty clinics each require distinct pricing, training and service packages to align with purchasing behaviors. Finally, strategic partnerships with payers, academic collaborators and systems integrators can accelerate market access and broaden referral networks. Executives who operationalize these priorities-by setting clear metrics, allocating cross-functional resources and maintaining agile governance-will be better positioned to convert technological promise into durable clinical and commercial impact.

Rigorous research methodology describing primary and secondary data, expert interviews, validation steps, segmentation logic and analytical techniques

The research methodology underpinning this analysis adheres to rigorous primary and secondary evidence collection, expert validation and transparent segmentation logic. Primary research activities included structured interviews with clinical opinion leaders, procurement professionals and technology executives to capture frontline perspectives on clinical workflows, adoption barriers and purchasing priorities. Secondary research drew on peer-reviewed literature, regulatory clearances and public filings to triangulate clinical outcomes, device characteristics and pathway evolution.

Validation steps incorporated cross-checks between interview insights and published data, while analytical techniques combined qualitative thematic synthesis with structured segmentation frameworks to surface actionable conclusions. The segmentation logic maps imaging guidance options, delivery modes, technological categories, product form factors, clinical applications and end-user settings to observed adoption behaviors and operational constraints. Throughout the process, quality controls ensured that assumptions were documented, sources were traceable and interpretations were anchored to empirical evidence.

This methodological approach balances depth of clinical insight with operational rigor to provide stakeholders a dependable foundation for strategic decisions and follow-on analysis.

Conclusion synthesizing strategic takeaways, emergent risks and opportunities, and actions leaders should pursue to navigate the focused ultrasound landscape

In synthesis, the high intensity focused ultrasound landscape presents a compelling mix of clinical promise and operational complexity that requires disciplined strategic action. Key takeaways emphasize the importance of aligning device capabilities with clinical workflows, demonstrating clear patient-centered outcomes and packaging value in ways that are meaningful to procurement and reimbursement stakeholders. Emergent risks include supply chain disruptions, regulatory variability across jurisdictions and the need for robust evidence to unlock wider payer support.

Opportunities are concentrated where technology attributes reduce procedural burden, expand the settings of care and provide measurable improvements in patient experience or health-system efficiency. Organizations that can integrate clinical validation, scalable manufacturing and pragmatic commercialization will capture the most durable advantage. Leaders should adopt a proactive posture-investing in supply chain resilience, tailoring go-to-market models by end-user setting, and cultivating payer and clinical partnerships that support broader adoption.

Ultimately, clear strategic focus, evidence-aligned execution and operational adaptability will determine which stakeholders successfully convert innovation into sustained clinical and commercial impact in this evolving therapeutic area.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of MR-guided HIFU systems enabling precise real-time tumor ablation in oncology applications
  • 5.2. Introduction of AI-powered treatment planning software optimizing acoustic beam parameters for personalized HIFU therapy
  • 5.3. Rising adoption of HIFU for noninvasive uterine fibroid treatment driven by improved patient outcomes and faster recovery
  • 5.4. Expansion of high-intensity focused ultrasound applications into neurological disorders such as essential tremor and Parkinson's disease
  • 5.5. Integration of real-time thermometry monitoring solutions to enhance safety and efficacy of HIFU tissue ablation procedures
  • 5.6. Development of compact, portable HIFU devices facilitating point-of-care treatments in outpatient and rural healthcare settings
  • 5.7. Growing focus on advanced transducer array designs improving focal spot control and depth penetration in HIFU platforms
  • 5.8. Regulatory approvals and evolving reimbursement frameworks accelerating HIFU adoption across major global healthcare markets
  • 5.9. Emergence of hybrid HIFU and radiotherapy protocols to synergistically target resistant cancer lesions
  • 5.10. Increasing integration of ultrasound imaging modalities to provide guided visualization during HIFU treatments

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High Intensity Focused Ultrasound Devices Market, by Guidance

  • 8.1. MRI Guided
  • 8.2. Ultrasound Guided

9. High Intensity Focused Ultrasound Devices Market, by Delivery Mode

  • 9.1. Extracorporeal
  • 9.2. Interstitial
  • 9.3. Intracavitary

10. High Intensity Focused Ultrasound Devices Market, by Technology

  • 10.1. Mechanical Ablation
  • 10.2. Thermal Ablation
    • 10.2.1. Continuous Wave
    • 10.2.2. Pulsed Wave

11. High Intensity Focused Ultrasound Devices Market, by Product

  • 11.1. Portable
  • 11.2. Stationary

12. High Intensity Focused Ultrasound Devices Market, by Application

  • 12.1. Liver Tumor
  • 12.2. Pancreatic Tumor
  • 12.3. Prostate Cancer
  • 12.4. Uterine Fibroids

13. High Intensity Focused Ultrasound Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. High Intensity Focused Ultrasound Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. High Intensity Focused Ultrasound Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. High Intensity Focused Ultrasound Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Chongqing Haifu Medical Technology Co., Ltd.
    • 17.3.2. Insightec Ltd.
    • 17.3.3. EDAP TMS S.A.
    • 17.3.4. SonaCare Medical LLC
    • 17.3.5. Alpinion Medical Systems Co., Ltd.
    • 17.3.6. GE HealthCare Technologies Inc.
    • 17.3.7. Siemens Healthineers AG
    • 17.3.8. Koninklijke Philips N.V.
    • 17.3.9. Hitachi, Ltd.
    • 17.3.10. THERACLION S. A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)